May 13, 2022 08:29pm
Announced on May 13, the approval indicates Eli Lilly and Company's novel dual GLP-1/GIP agonist, tirzepatide (Mounjaro), for use as an adjunct to diet and exercise to improve blood sugar in adult patients with type 2 diabetes.
May 13, 2022 07:14pm
May 13, 2022 04:12pm
May 13, 2022 03:57pm
May 13, 2022 01:02pm
May 12, 2022
A session at the 40th Annual Meeting of the European Society for Pediatric Infectious Diseases looks at how the pandemic impacted the used of antimicrobials.
Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.
Investigators examined whether rapid antigen tests were less sensitive to variants of concern. Though the tests detected Omicron, all but 1 were less effective in detecting the Delta variant.
May 11, 2022
An analysis of data from more than 3500 individuals followed for more than 20 years provides insight into the impact of food insecurity on risk of cardiometabolic conditions, including obesity and type 2 diabetes.
Home environments have a clear impact on depression treatment outcomes.